Results from a systematic programme of evaluating COVID-19 reinfection cases in the early phase of the pandemic, Singapore
Objectives: The objectives of this study were to describe the coronavirus disease caused by SARS-CoV-2 (COVID-19) reinfection evaluation algorithm used in the early phase of the pandemic in Singapore and analyze the clinical and laboratory characteristics of the cases evaluated. Methods: We performe...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
2023
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/169545 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
id |
sg-ntu-dr.10356-169545 |
---|---|
record_format |
dspace |
spelling |
sg-ntu-dr.10356-1695452023-07-30T15:37:52Z Results from a systematic programme of evaluating COVID-19 reinfection cases in the early phase of the pandemic, Singapore Tan, Glorijoy Shi En Gao, Christine Qiuhan Ow, Jievanda Shu Ying Tan, Thuan Thong Ooi, Say Tat Lin, Cui Lin, Raymond Tzer Pin Lee, Vernon Jian Ming Chan, Monica Leo, Yee Sin Vasoo, Shawn Lee Kong Chian School of Medicine (LKCMedicine) Tan Tock Seng Hospital National Centre for Infectious Diseases, Singapore Science::Medicine COVID-19 SARS-CoV-2 Objectives: The objectives of this study were to describe the coronavirus disease caused by SARS-CoV-2 (COVID-19) reinfection evaluation algorithm used in the early phase of the pandemic in Singapore and analyze the clinical and laboratory characteristics of the cases evaluated. Methods: We performed a retrospective case-control analysis including all COVID-19 cases evaluated for possible reinfection under the local COVID-19 reinfection evaluation programme between 1 June 2020-30 June 2021. Whole genome sequencing (WGS) was used as confirmatory testing. We compared all reinfection (“RI”) cases against those who were evaluated but eventually assessed not to be reinfection (“non-RI”). Results: There were 74 possible reinfection cases evaluated through the programme, of which 32 were subsequently classified as RI. There was strong statistical evidence that RI cases had a longer interval between 1st and 2nd episode (mean 297 days; 95%-confidence interval (CI) 267–327) compared to non-RI cases (mean 186 days; 95%-CI 144–228). The cycle threshold (Ct) value of initial polymerase chain rection (PCR) at 2nd episode was also found to be significantly lower in RI cases (mean 23; 95%-CI 20–26) compared to non-RI cases (mean 34; 95%-CI 32–36). There was no significant difference in the proportion of individuals who had fever, acute respiratory symptoms or asymptomatic in both groups. Delta and beta variants were most commonly identified from WGS and provide indication of re-infection as these were not ‘wild-type’ and were not circulating during the time period of the index infection. Conclusions: Using a combination of serologic, microbiologic and genomic criteria to evaluate possible reinfection cases is useful and can provide a framework for evaluation that may be modified for future similar situations. Published version 2023-07-24T02:53:50Z 2023-07-24T02:53:50Z 2023 Journal Article Tan, G. S. E., Gao, C. Q., Ow, J. S. Y., Tan, T. T., Ooi, S. T., Lin, C., Lin, R. T. P., Lee, V. J. M., Chan, M., Leo, Y. S. & Vasoo, S. (2023). Results from a systematic programme of evaluating COVID-19 reinfection cases in the early phase of the pandemic, Singapore. BMC Infectious Diseases, 23(1), 93-. https://dx.doi.org/10.1186/s12879-023-08056-8 1471-2334 https://hdl.handle.net/10356/169545 10.1186/s12879-023-08056-8 36788516 2-s2.0-85148087911 1 23 93 en BMC Infectious Diseases © The Author(s) 2023. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. application/pdf |
institution |
Nanyang Technological University |
building |
NTU Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NTU Library |
collection |
DR-NTU |
language |
English |
topic |
Science::Medicine COVID-19 SARS-CoV-2 |
spellingShingle |
Science::Medicine COVID-19 SARS-CoV-2 Tan, Glorijoy Shi En Gao, Christine Qiuhan Ow, Jievanda Shu Ying Tan, Thuan Thong Ooi, Say Tat Lin, Cui Lin, Raymond Tzer Pin Lee, Vernon Jian Ming Chan, Monica Leo, Yee Sin Vasoo, Shawn Results from a systematic programme of evaluating COVID-19 reinfection cases in the early phase of the pandemic, Singapore |
description |
Objectives: The objectives of this study were to describe the coronavirus disease caused by SARS-CoV-2 (COVID-19) reinfection evaluation algorithm used in the early phase of the pandemic in Singapore and analyze the clinical and laboratory characteristics of the cases evaluated. Methods: We performed a retrospective case-control analysis including all COVID-19 cases evaluated for possible reinfection under the local COVID-19 reinfection evaluation programme between 1 June 2020-30 June 2021. Whole genome sequencing (WGS) was used as confirmatory testing. We compared all reinfection (“RI”) cases against those who were evaluated but eventually assessed not to be reinfection (“non-RI”). Results: There were 74 possible reinfection cases evaluated through the programme, of which 32 were subsequently classified as RI. There was strong statistical evidence that RI cases had a longer interval between 1st and 2nd episode (mean 297 days; 95%-confidence interval (CI) 267–327) compared to non-RI cases (mean 186 days; 95%-CI 144–228). The cycle threshold (Ct) value of initial polymerase chain rection (PCR) at 2nd episode was also found to be significantly lower in RI cases (mean 23; 95%-CI 20–26) compared to non-RI cases (mean 34; 95%-CI 32–36). There was no significant difference in the proportion of individuals who had fever, acute respiratory symptoms or asymptomatic in both groups. Delta and beta variants were most commonly identified from WGS and provide indication of re-infection as these were not ‘wild-type’ and were not circulating during the time period of the index infection. Conclusions: Using a combination of serologic, microbiologic and genomic criteria to evaluate possible reinfection cases is useful and can provide a framework for evaluation that may be modified for future similar situations. |
author2 |
Lee Kong Chian School of Medicine (LKCMedicine) |
author_facet |
Lee Kong Chian School of Medicine (LKCMedicine) Tan, Glorijoy Shi En Gao, Christine Qiuhan Ow, Jievanda Shu Ying Tan, Thuan Thong Ooi, Say Tat Lin, Cui Lin, Raymond Tzer Pin Lee, Vernon Jian Ming Chan, Monica Leo, Yee Sin Vasoo, Shawn |
format |
Article |
author |
Tan, Glorijoy Shi En Gao, Christine Qiuhan Ow, Jievanda Shu Ying Tan, Thuan Thong Ooi, Say Tat Lin, Cui Lin, Raymond Tzer Pin Lee, Vernon Jian Ming Chan, Monica Leo, Yee Sin Vasoo, Shawn |
author_sort |
Tan, Glorijoy Shi En |
title |
Results from a systematic programme of evaluating COVID-19 reinfection cases in the early phase of the pandemic, Singapore |
title_short |
Results from a systematic programme of evaluating COVID-19 reinfection cases in the early phase of the pandemic, Singapore |
title_full |
Results from a systematic programme of evaluating COVID-19 reinfection cases in the early phase of the pandemic, Singapore |
title_fullStr |
Results from a systematic programme of evaluating COVID-19 reinfection cases in the early phase of the pandemic, Singapore |
title_full_unstemmed |
Results from a systematic programme of evaluating COVID-19 reinfection cases in the early phase of the pandemic, Singapore |
title_sort |
results from a systematic programme of evaluating covid-19 reinfection cases in the early phase of the pandemic, singapore |
publishDate |
2023 |
url |
https://hdl.handle.net/10356/169545 |
_version_ |
1773551345123459072 |